This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
AeonClad Coatings, LLC, an advanced materials company focusing on improving the performance of existing products for new applications, has announced the company’s expansion into a new research and development facility located in Austin, TX, USA. With the new facility, AeonClad will demonstrate how semiconductor plasma processing techniques and equipment can be adapted to handle a wider range of materials, shapes, and sizes such as powdered plastic additives, consumer apparel, and novel drug formulations.


http://www.aeonclad.com


Alexium International Group Limited (ASX:AJX, AX:AJX, OTC QX:AXXIY) is reaffirming its strategic focus on providing unique, environmentally friendly flame retardant (FR) chemistries. As the public and government agencies across the world are increasing pressure to phase out traditional bromine-based flame retardants due to environmental and health concerns, Alexium is introducing a safe and effective bromine-free FR alternative for several industrial applications. Alexium’s highly effective and durable flame retardant treatments do not contain organo-bromine or any other halogenated compounds. While the Company is already rolling out commercial fabric applications of its novel FR chemistry, it will be focusing on entering new product areas, such as carpet, furnishings, polyurethane foam padding, insulation, plastics, and aerospace interiors. Alexium is currently finalizing a full licence agreement for FR treatments for nylon with Duro Textiles, one of the United States' largest finishers and dyers, to address a market opportunity in excess of 3.66 million linear metres (4 million linear yards) of nylonfabric. The main commercial terms for this FR Nylon licence were previously announced and wider licence terms are now being finalized.


http://www.alexiuminternational.com 


For the second quarter of 2012, AMCOL International Corporation (ACO) generated diluted earnings per share attributable to its shareholders from continuing operations of $0.65 per share versus $0.42 per share in the prior year‘s quarter. Net sales increased 6.1% to $257.5 million for the 2012 se- cond quarter as compared to $242.8 million for the 2011 period. Excluding the effects of foreign currency exchange rate fluctuations, revenues would have increased 9.1%. Gross profit increased 19.5% while gross margin increased 320 basis points to 28.8%. Selling, general and administrative expenses increased 7.4% to $43.3 million. Operating profit increased 41.7% with operating profit margins increasing by 300 basis points to 12.0%. Our effective tax rate for the 2012 quarter was 28.3%. Net sales increased $14.7 million or 6.1%.


AMCOL International also reports that the Board of Directors has declared a quarterly dividend of $0.20 per share, payable on October 9, 2012 to shareholders of record as of August 29, 2012.


http://www.amcol.com


 

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105